Search hospitals > New Hampshire > Manchester
Norris Cotton Cancer Center-Manchester
Claim this profileManchester, New Hampshire 03102
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
62 reported clinical trials
5 medical researchers
Summary
Norris Cotton Cancer Center-Manchester is a medical facility located in Manchester, New Hampshire. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Norris Cotton Cancer Center-Manchester is involved with conducting 62 clinical trials across 221 conditions. There are 5 research doctors associated with this hospital, such as Kathryn C. Hourdequin, Konstantin H. Dragnev, Gabriel A. Brooks, and Mary D. Chamberlin.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Kathryn C. HourdequinDartmouth Hitchcock Medical Center/Dartmouth Cancer Center5 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
19 reported clinical trials
35 drugs studied
Konstantin H. DragnevDartmouth Hitchcock Medical Center5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
42 drugs studied
Gabriel A. BrooksDartmouth Hitchcock Medical Center6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
9 reported clinical trials
25 drugs studied
Mary D. ChamberlinDartmouth Hitchcock Medical Center8 years of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
15 drugs studied
Clinical Trials running at Norris Cotton Cancer Center-Manchester
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
ALK Gene Rearrangement
Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Norris Cotton Cancer Center-Manchester?
Norris Cotton Cancer Center-Manchester is a medical facility located in Manchester, New Hampshire. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Norris Cotton Cancer Center-Manchester is involved with conducting 62 clinical trials across 221 conditions. There are 5 research doctors associated with this hospital, such as Kathryn C. Hourdequin, Konstantin H. Dragnev, Gabriel A. Brooks, and Mary D. Chamberlin.